ArticleScientific reports2025
Evaluation of genetic instability of short tandem repeats in hepatocellular carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hepatocellular carcinoma (HCC) ranked as the sixth most common malignancy and the third leading cause of cancer-related mortality with approximately 830, 000 deaths worldwide annually. Genetic instability of short tandem repeats (STRs), which manifested as loss of heterozygosity (LOH) or microsatellite instability (MSI) in the cancerous cells, is a genetic feature of many types of human cancers. The status of STR instablility and its clinical significance in HCC, however, remains to be comprehensively elucidated. In this study, a total of 101 matched DNA samples from HCC individuals were analyzed with 20 "classical STR markers widely used in forensic genetics, our findings demonstrated that 79.21% (80/101) of HCC cases exhibited genetic alterations in at least 1 STR locus, with 16.73% of STR loci altered across all samples. Moreover, our findings also revealed a significant association between an accumulation of STR alterations and the presence of positive hepatitis B surface antigen (HBsAg), as well as moderate-poor/poor differentiation of HCC. Furthermore, LOH at the FGA was found to be significantly correlated with moderate-poor/poor differentiation of HCC (p = 0.002), and LOH at the D16S539 was found to be significantly associated with elevated serum levels of AFP (p = 0.042) as well as larger tumor sizes (p = 0.040). Overall, this study contributes valuable insights into the genetic instability of STRs in HCC and might also enhance insights into the intricate mechanisms underlying hepatocarcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.